Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. In Memoriam: Arvid Carlsson-Pioneering Researcher and Nobel Laureate

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The structure of the serotonin system: A PET imaging study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The main psychedelic component of magic mushrooms is psilocybin, which shows promise as a treatment for depression and other mental disorders. Psychedelic effects are believed to emerge through stimulation of serotonin 2A receptors (5-HT2ARs) by psilocybin's active metabolite, psilocin. We here report for the first time the relationship between intensity of psychedelic effects, cerebral 5-HT2AR occupancy and plasma levels of psilocin in humans. Eight healthy volunteers underwent positron emission tomography (PET) scans with the 5-HT2AR agonist radioligand [11C]Cimbi-36: one at baseline and one or two additional scans on the same day after a single oral intake of psilocybin (3-30 mg). 5-HT2AR occupancy was calculated as the percent change in cerebral 5-HT2AR binding relative to baseline. Subjective psychedelic intensity and plasma psilocin levels were measured during the scans. Relations between subjective intensity, 5-HT2AR occupancy, and plasma psilocin levels were modeled using non-linear regression. Psilocybin intake resulted in dose-related 5-HT2AR occupancies up to 72%; plasma psilocin levels and 5-HT2AR occupancy conformed to a single-site binding model. Subjective intensity was correlated with both 5-HT2AR occupancy and psilocin levels as well as questionnaire scores. We report for the first time that intake of psilocybin leads to significant 5-HT2AR occupancy in the human brain, and that both psilocin plasma levels and 5-HT2AR occupancy are closely associated with subjective intensity ratings, strongly supporting that stimulation of 5-HT2AR is a key determinant for the psychedelic experience. Important for clinical studies, psilocin time-concentration curves varied but psilocin levels were closely associated with psychedelic experience.

Original languageEnglish
JournalNeuropsychopharmacology
Volume44
Issue number7
Pages (from-to)1328-1334
Number of pages7
ISSN0893-133X
DOIs
Publication statusPublished - Jun 2019

ID: 56708623